Sigma Planning Corp Moderna, Inc. Transaction History

Sigma Planning Corp

$3.11 Billion
Q1 2024

A detailed history of Sigma Planning Corp transactions in Moderna, Inc. stock. As of the latest transaction made, Sigma Planning Corp holds 3,313 shares of MRNA stock, worth $389,078. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,313

Previous 2,777 19.3%

Holding current value

$389,078

Previous $276,000 27.9%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$85.37 - $115.44 $45,758 - $61,875	536 Added 19.3%	3,313 $353,000
Q4 2023 Feb 01, 2024	SELL	$69.51 - $104.43 $502,418 - $754,820	-7,228 Reduced 72.24%	2,777 $276,000
Q3 2023 Nov 06, 2023	SELL	$96.41 - $126.61 $147,314 - $193,460	-1,528 Reduced 13.25%	10,005 $1.03 Million
Q2 2023 Aug 01, 2023	BUY	$118.5 - $160.53 $16,234 - $21,992	137 Added 1.2%	11,533 $1.4 Million
Q1 2023 May 05, 2023	SELL	$135.66 - $197.02 $91,027 - $132,200	-671 Reduced 5.56%	11,396 $1.75 Million

Q4 2022 Jan 24, 2023	BUY	$118.38 - $210.04 $75,644 - $134,215	639 Added 5.59%	12,067 $0
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $10,508 - $17,282	-89 Reduced 0.77%	11,428 $1.35 Million
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $5,387 - $8,123	46 Added 0.4%	11,517 $1.65 Million
Q1 2022 Apr 20, 2022	SELL	$126.46 - $235.05 $69,426 - $129,042	-549 Reduced 4.57%	11,471 $1.98 Million
Q4 2021 Feb 02, 2022	SELL	$225.82 - $368.51 $3.43 Million - $5.59 Million	-15,178 Reduced 55.81%	12,020 $3.05 Million
Q3 2021 Oct 28, 2021	BUY	$221.9 - $484.47 $3.1 Million - $6.77 Million	13,973 Added 105.66%	27,198 $10.5 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $51,574 - $93,287	397 Added 3.09%	13,225 $3.11 Million
Q1 2021 May 06, 2021	SELL	$109.18 - $185.98 $44,545 - $75,879	-408 Reduced 3.08%	12,828 $1.68 Million
Q4 2020 Feb 09, 2021	SELL	$65.74 - $169.86 $253,887 - $655,999	-3,862 Reduced 22.59%	13,236 $1.38 Million
Q3 2020 Nov 03, 2020	SELL	$54.34 - $94.85 $55,155 - $96,272	-1,015 Reduced 5.6%	17,098 $1.21 Million
Q2 2020 Jul 31, 2020	BUY	$29.67 - $80.0 $236,113 - $636,640	7,958 Added 78.37%	18,113 $1.16 Million
Q1 2020 May 01, 2020	BUY	$17.78 - $31.58 $180,555 - $320,694	10,155 New	10,155 $304,000

Others Institutions Holding MRNA

# of Institutions

1,040

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account

Sigma Planning Corp Moderna, Inc. Transaction History